Richard Cook
Corporate Officer/Principal bij University of British Columbia
Profiel
Richard Cook is an Associate Professor at the University of British Columbia, where he has been working since 2013.
Prior to his current position, he worked as the Chief Medical Officer at Avagenesis Corp.
and Enlighta, Inc. Cook holds a doctorate degree from the University of Alberta and a graduate degree from the University of British Columbia.
Actieve functies van Richard Cook
| Bedrijven | Functie | Begin |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 01-01-2013 |
Eerdere bekende functies van Richard Cook
| Bedrijven | Functie | Einde |
|---|---|---|
| ENLIGHTA INC. | Hoofd Techniek/Wetenschap/O&O | - |
Avagenesis Corp.
 Avagenesis Corp. Miscellaneous Commercial ServicesCommercial Services Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Richard Cook
| University of Alberta | Doctorate Degree |
| University of British Columbia | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENLIGHTA INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Avagenesis Corp.
Avagenesis Corp. Miscellaneous Commercial ServicesCommercial Services Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada. | Commercial Services |